An end-to-end pharma partner — discovery, clinical supply, GMP manufacturing and regulatory affairs, under one accountable roof.
Handoffs between vendors lose time, data integrity and — ultimately — patients' chances.
Discovery, trials and manufacturing rarely speak the same language.
One data-integrity gap can derail an entire submission.
Every delayed batch pushes back a life-changing therapy.
From assay to approval — a single, data-integral chain of custody with science you can audit at any moment.
Screening, assays and lead optimisation.
Process & formulation, scale-up to GMP.
Clinical supply, dossiers and submission.
Medicinal chemistry, biology and DMPK.
Sterile & non-sterile, small to commercial scale.
IND/IMPD, NDA/MAA, global submissions.
21 CFR Part 11, ALCOA+ across every system.
Validated 2–8°C and cryogenic logistics.
Safety monitoring and reporting built in.
For early-stage research.
For IND-enabling work.
For approved products.
Yes — our facilities are GMP-certified and operate to FDA, EMA and ICH standards with full 21 CFR Part 11 systems.
Our in-house regulatory team handles IND/IMPD through NDA/MAA across major markets.
Strict segregation, audited access controls and watertight confidentiality agreements.
From gram-scale clinical batches to commercial-scale production.
Book a confidential consultation with our scientific team.
Tell us about your program — we'll respond within one business day.